CA 02644665 2008-09-03
LIGAND, METHOD FOR PRODUCING THE SAME, AND
CATALYST USING THE LIGAND
Technical Field
The present invention relates to a novel ligand and a method
for producing the ligand, and a catalyst using the ligand.
Background Art
The present inventors, or some of the present inventors,
or inventors partly including the present inventors have
developed a variety of asymmetric ligands having a glucose as
a mother nucleus and catalysts therewith (see Patent Document
1 and the like) , and have found that the catalysts can promote
a variety of catalytically asymmetric reactions such as a
catalytically asymmetric cyanation to ketone or ketoimi.ne, a
catalytically asymmetric conjugate addition reaction of a cyano
group to a,(3-unsaturated carboxylic acid derivatives and a
catalytically asymmetric ring opening reaction due to a cyano
group of aziridine.
Patent Document 1: Japanese Patent No. 3671209
Disclosure of Invention
Problem to be solved by the Invention
However, since many steps are necessary to synthesize an
asymmetric ligand having a glucose as a mother nucleus
(hereinafter, in some cases, simply referred to as
NN glucose-derived ligand"), the ligand was disadvantageous from
1
CA 02644665 2008-09-03
a standpoint of cost.
Further, it still has a need for catalysts having higher
catalytic activity and higher enantioselectivity as well.
An object of the present invention is to provide a riovel
asymmetric ligand that is synthesized by a short production
process at low cost and a producing method thereof, and a catalyst
using the novel ligand.
Further, other than or in addition to the above-described
objects, an object of the present invention is to provide a novel
asymmetric ligand that is capable of developing the catalyst
activity and enantioselectivity higher than that of a
conventional glucose-derived ligand and a producing method
thereof, and a catalyst using the novel ligand.
In particular, an object of the present invention is to
provide, in a catalytically asymmetric ring opening reaction
in a cyano group of aziridine, which is useful for synthesizing
an optically active (3-amino acid, a novel asymmetric ligand that
is capable of developing functions such as catalyst activity
and enantioselectivity excellent more than that of aconventional
glucose-derived ligand and a producing method thereof, and a
catalyst using the novel ligand.
Means for Solving Problem
The present inventors have found that the following
inventions can solve the above-described problems:
<1> A ligand represented by following general formula I:
2
CA 02644665 2008-09-03
Ri
R2~ X
~II A n I
p )m
HO p A,
AZ
HO ( A3
A4
wherein each of R' and R2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trifluoroacetyl group, a trifluoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms), an amino
group represented by -NRbRc (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3.
<2> A ligand represented by following general formula Ia:
R~
I ~.
R2~
~~-X'E~
0 m Ia
HO p Al
~A2
1
HO A4 3
CA 02644665 2008-09-03
wherein each of R' and R2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group,anitro group, a trif luoroacetyl group, a trifluoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms) , an amino
group represented by -NRbRc (each of Rb and R' independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3.
<3> A ligand represented by following general formula Ib:
R1
R2~(I
II n
a m Ib
HO ~ A,
A2
HO A3
A4 f
wherein each of R' and R2 independently represents 0 to
5 substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trifluoromethyl
4
CA 02644665 2008-09-03
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms), an amino
group represented by -NRbRc (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3.
<4> In any one of the above items <1> to <3>, n may be
an integer of 0 or 1, and preferably 0.
<5> In any one of the above items <1> to <4>, m may be
an integer of 2 to 4, and preferably 2 or 3.
<6> In any one of the above items <1> to <5>, two of
the A1 to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<7> A method of producing a ligand represented by
following general formula I from a compound represented by
following general formula II:
Ri
Rz~
-II A n
O Im I
HO O A,
A2
HO A3
A4
wherein each of R1 and R 2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
5
CA 02644665 2008-09-03
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Rd represents a linear
or branched alkyl group having 1 to 4 carbon atoms) , an amino
group represented by -NRbRc (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms ), a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
o /m
O Al A2 II
R3O j[>A3
A4
.
wherein R3 represents a hydrogen atom, a linear or branched
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of Al to A4 independently
has the same definition as described above,
the method comprising the steps of:
a) reacting the compound represented by the general formula
II with a metal salt of diphenylphosphine, diarylphosphine or
diarylamine;
b) thereafter, processing with ammonium chloride and
6
CA 02644665 2008-09-03
hydrogen peroxide; and
b' ) when X is As or N and R3 is one other than a hydrogen
atom, allowing palladium-carbon to react with hydrogen, lithium
chloride, dichlorodicyanobenzoquinone, cerium ammonium nitrate
or a fluorine anion to make the R3 a hydrogen atom, to obtain
the ligand represented by the general formula I.
<8> In the above item <7>, the compound represented by
the general formula II may be obtained by c) reacting a compound
represented by following general formula III, wherein m has the
same definition as described above, in the presence of
diethylazodicarboxylate or diisopropylazodicarboxylate and
triphenylphosphine or tributylphosphine, with a compound
represented by following general formula IV, wherein R3 and Al
to A4 have the same definitions as described above:
O )m III
OH
HO Al ~ A2
I IV
R3O ~ A3
A4
<9> In the above item <8>, the compound represented by
the general formula III may be obtained by d) reacting a compound
represented by following general formula V, wherein m has the
same definition as described above, in the presence of a
phosphoric acid buffer, with a peracid:
[I )m v
OH
7
CA 02644665 2008-09-03
<10> A method of producing a ligand represented by
following general formula Ia from a compound represented by
following general formula IIa:
Ri
RZ~CI X
11 n
O ) m Ia
H O 0 Al
:>A A2
HO 3
1
A4
wherein each of R' and R2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trifluoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms) , an amino
group represented by -NRbRc (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to-4 carbon atoms), a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
O Al
~ A2 IIa
R3O A3
A4
8
CA 02644665 2008-09-03
wherein R3 represents a hydrogen atom, a linear or branched
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of A1 to A4 independently
has the same definition as described above,
the method comprising the steps of:
a) reacting the compoundrepresented by thegeneralformula
IIa with a metal salt of diphenylphosphine, diarylphosphine or
diarylamine;
b) thereafter, processing with ammonium chloride and
hydrogen peroxide; and
b' ) when X is As or N and R3 is one other than a hydrogen
atom, allowing palladium-carbon to react with hydrogen, lithium
chloride,dichlorodicyanobenzoquinone,cerium ammonium nitrate
or a fluorine anion to make the R3 a hydrogen atom, to obtain
the ligand represented by the general formula Ia.
<11> In the above item <10>, the compound represented
by the general formula I Ia maybe obtained by c) reacting a compound
represented by following general formula IIIa, wherein m has
the same definition as described above, in the presence of
diethylazodicarboxylate or diisopropylazodicarboxylate and
triphenylphosphine or tributylphosphine, with a compound
represented by following general formula IV, wherein R3 and A1
to A4 have the same definitions as described above:
F~/m
IIIa
OH
9
CA 02644665 2008-09-03
HO A, ~ A2
~ IV
R30 ~ A3
A4
<12> In the above item <11>, the compound represented
by the general formula IIIa may be obtained by d) reacting a
compound represented by following general formula Va, wherein
m has the same definition as described above, in the presence
of a phosphoric acid buffer, with a peracid:
m Va
OH
<13> A method of producing a ligand represented by
following general formula Ib from a compound represented by
following general formula IIb:
R~
2
R
11 n
o ) m Ib
HO ~ A,
~ A2
HO (~ A3
A4
wherein each of R1 and R2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
CA 02644665 2008-09-03
or branched alkyl group having 1 to 4 carbon atoms ), an amino
group represented by -NRbRC (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
O~ ) m
0 A,
A2 IIb
R30) A3
A4
wherein R3 represents a hydrogen atom, a linear or branched
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of Al to A4 independently
has the same definition as described above,
the method comprising the steps of:
a) reacting the compound represented by the generalformula
IIb with a metal salt of diphenylphosphine, diarylphosphine or
diarylamine;
b) thereafter, processing with ammonium chloride and
hydrogen peroxide; and
b' ) when X is As or N and R3 is one other than a hydrogen
atom, allowing palladium-carbon to react with hydrogen, lithium
chloride,dichlorodicyanobenzoquinone,ceriumamrnonium nitrate
or a fluorine anion to make the R3 a hydrogen atom, to obtain
the ligand represented by the general formula Ib.
11
CA 02644665 2008-09-03
<14> In the above item <13>, the compound represented
by the general formula I Ib may be obtained by c) reacting a compound
represented by following general formula IIIb, wherein m has
the same definition as described above, in the presence of
diethylazodicarboxylate or diisopropylazodicarboxylate and
triphenylphosphine or tributylphosphine, with a compound
represented by following general formula IV, wherein R3 and A1
to A4 have the same definitions as described above:
<4)m IIIb
OH
HO A, ~ AZ
~ IV
R30 ~ A3
A4
<15> In the above item <14>, the compound represented
by the general formula IIIb may be obtained by d) reacting a
compound represented by following general formula Vb, wherein
m has the same definition as described above, in the presence
of a phosphoric acid buffer, with a peracid:
[I)m Vb
OH
<16> In any one of the above items <7> to <15>, n may
be an integer of 0 or 1, and preferably 0.
<17> In any one of the above items <7> to <16>, m may
be an integer of 2 to 4, and preferably 2 or 3.
<18> In any one of the above items <7> to <17>, two of
the Al to A4 may be hydrogen atoms and the other two thereof
12
CA 02644665 2008-09-03
may be fluorine atoms, preferably Al and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<19> In any one of the above items <7> to <18>, R3 may
be a methyl group.
<20> A producing method of a ligand represented by
following general formula I from a compound represented by
following general formula II:
Ri
I ~.
R2
o A lm
A2
HO O A, >A3
HO I A4
wherein each of R1 and R 2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of A1 to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms), an amino
group represented by -NRbRC (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms ), a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
13
CA 02644665 2008-09-03
o Im
O At
A2 II
R3O A3
4
wherein R3 represents a hydrogen atom, a linear or branched
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of Al to A4 independently
has the same definition as described above,
the method comprising the steps of:
g) reacting the compound representedby the general formula
II with diethylaluminum cyanide, followed by reacting with
concentrated hydrochloric acid, to obtain a compound represented
by following general formula VII, wherein m, R3 and Al to A4 have
the same definitions as described above;
h) reacting the compound represented by the general formula
VII with a BH3 tetrahydrofuran complex, a BH3 dimethylsulfide
complex or LiAlH4r to obtain a compound represented by following
general formula VIII, wherein m, R3 and Al to A4 have the same
definitions as described above;
j) reacting the compound represented by the general formula
VIII with p-toluenesulfonyl chloride, to obtain a compound
represented by following general formula IX, wherein Ts
represents a p-toluenesulfonyl group; and m, R3 and Al to A4 have
the same definitions as described above;
14
CA 02644665 2008-09-03
k) reacting the compound representedby the general formula
IX with potassium diphenyl phosphide, followed by reacting with
hydrogen peroxide, to obtain a compound represented by following
general formula X, wherein m, R3 and A1 to A4 have the same
definitions as described above; and
1) reacting the compound represented by the general formula
X with lithium iodide, to obtain the ligand represented by the
general formula I:
O
HO }
m
HO O A, ~ A2 VII
R3O ~r A3
A4
HO )
m
HO O Al ~ A2 VIII
R3O ~~ A3
Aa
Ts0 ) ZE m
HO O A,
A2 ix
R30 j[: A3
A4
Ri
R2 0 m
HO 0 A, X
~ AZ
~
R30 ~ A3
A4
<21> A method of producing a ligand represented by
CA 02644665 2008-09-03
following general formula Ia from a compound represented by
following general formula IIa:
Ri
R2 \ X
11 n
O Im Ia
HO~~ 0
~ A2
HO C~ A3
A4 wherein each of R1 and R 2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms ), an amino
group represented by -NRbRC (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
Q r"'' /m
,,,,
O
~ 11 AZ IIa
RO A3
A4
wherein R3 represents a hydrogen atom, a linear or branched
16
CA 02644665 2008-09-03
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of A1 to A4 independently
has the same definition as described above,
the method comprising the steps of:
g) reacting a compound represented by the general formula
IIa with diethylaluminum cyanide, followed by reacting with
concentrated hydrochloric acid, to obtain a compound represented
by following general formula VIIa, wherein m, R3 and Al to A4
have the same definitions as described above;
h) reacting the compound represented bythe generalformula
VIIa with a BH3 tetrahydrofuran complex, a BH3 dimethylsulfide
complex or LiAlH4r to obtain a compound represented by following
general formula VIIIa, wherein m, R3 and A1 to A4 have the same
definitions as described above;
j) reacting the compound represented bythegeneralformula
VIIIa with p-toluenesulfonyl chloride, to obtain a compound
represented by following general formula IXa, wherein Ts
represents a p-toluenesulfonyl group, and m, R3 and A1 to A4 have
the same definitions as described above;
k) reacting the compound representedby the general formula
IXa with potassium diphenyl phosphide, followed by reacting with
hydrogen peroxide, to obtain a compound represented by following
general formula Xa, wherein m, R3 and A1 to A4 have the same
definitions as described above; and
1) reacting the compound represented bythe general formula
17
CA 02644665 2008-09-03
Xa with lithium iodide, to obtain the ligand represented by the
general formula Ia:
0
HO )
m
Hd O A,
I ~ Az VIIa
R30 ~ A3
A4
HO )
m
HC O A,
)[: A2 VIIIa
R30 A3
A4
TsO )
m
HO~` O A,
A2 IXa
R30 )(>A3
A4
Ri
~
~ ~ X^
R 0
Hd O A, A2 Xa
~
~
R30 ~ A3
A4
<22> A method of producing a ligand represented by
following general formula Ib from a compound represented by
following general formula IIb:
18
CA 02644665 2008-09-03
Ri
R2~
II n
o ~ m lb
HO 0 A,
A2
HO ~ A3
A4
wherein each of R' and R 2 independently represents 0 to
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms) , an amino
group represented by -NRbRc (each of Rb and Rc independently
represents a hydrogen atom or a linear or branched alkyl group
having 1 to 4 carbon atoms ), a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3, and
O~ /m
0 A,
A2 IIb
R3O~ / A3
A4
wherein R3 represents a hydrogen atom, a linear or branched
alkyl group having 1 to 8 carbon atoms, a linear or branched
alkenyl group having 2 to 8 carbon atoms, a benzyl group, a
19
CA 02644665 2008-09-03
paramethoxy benzyl group or a silyl group; m has the same
definition as described above; and each of A1 to A4 independently
has the same definition as described above,
the method comprising the steps of:
g) reacting a compound represented by the general formula
IIb with diethylaluminum cyanide, followed by reacting with
concentrated hydrochloric acid, to obtain a compound represented
by following general formula VIIb, wherein m, R3 and Al to A4
have the same definitions as described above;
h) reacting the compound represented by the general formula
VIIb with a BH3 tetrahydrofuran complex, a BH3 dimethylsulfide
complex or LiAlH4r to obtain a compound represented by following
general formula VIIIb, wherein m, R3 and Al to A4 have the same
definitions as described above;
j) reacting the compoundrepresented bythe generalformula
VIIIb with p-toluenesulfonyl chloride, to obtain a compound
represented by following general formula IXb, wherein Ts
represents a p-toluenesulfonyl group, and m, R3 and A1 to A4 have
the same definitions as described above;
k) reacting the compound represented by the general formula
IXb with potassium diphenyl phosphide, followedby reacting with
hydrogen peroxide,to obtain a compound represented by following
general formula Xb, wherein m, R3 and A1 to A4 have the same
definitions as described above; and
1) reacting the compoundrepresented by thegeneralformula
Xb with lithium iodide, to obtain the ligand represented by the
general formula Ib:
CA 02644665 2008-09-03
O
HO~~ )
m
HO At
I ~ Az Vllb
R3O ~ A3
A4
HO)
m
HO 0 Al I ~ A2 VIIIb
R30 ~ A3
A4
TsO
m
HO ~ A,
I ~ A2 IXb
R30 A3
A4
Ri
X /m
R2 O
HO ~ A,
A2 Xb
~ \
R30 ~ 3
A4 <23> In any one of the above items <20> to <22>, n may
be an integer of 0 or 1, and preferably 0.
<24> In any one of the above items <20> to <23>, m may
be an integer of 2 to 4, and preferably 2 or 3.
<25> In any one of the above items <20> to <24>, two of
the A1 to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
21
CA 02644665 2008-09-03
<26> In any one of the above items <20> to <25>, R3 may
be a methyl group.
<27> A catalyst being formed of:
A) a metal alkoxide or a metal amide represented by MX (OR4) y
or Mx- (NR5)y,, wherein M is a metal selected from the group
consisting of titanium, zirconium, aluminum, gallium, barium
and rare earth elements; each of R4 and R5 independently
represents a substituted or non-substituted, linear or branched
or cyclic alkyl group having 2 to 6 carbon atoms, a substituted
or non-substituted, linear or branched or cyclic alkenyl group,
a substituted or non-substituted aromatic group or a
trialkylsilyl group, and x and y and x' and y' are integers
stoichiometrically determined by the metal M; and
B) a ligand represented by following general formula I,
wherein each of R' and R 2 independently represents 0 to 5
substituent groups; X represents P, As or N; m represents an
integer of 0 to 7; n represents an integer of 0 to 3; and each
of Al to A4 independently represents a hydrogen atom, a fluorine
atom, a chlorine atom, a bromine atom, a benzoyl group, an acetyl
group, a nitro group, a trif luoroacetyl group, a trif luoromethyl
group, an alkoxy group represented by -ORa (Ra represents a linear
or branched alkyl group having 1 to 4 carbon atoms ), an amino
group represented by -NRbRC (each of Rb and R' independently
represents a hydrogen atom, or a linear or branched alkyl group
having 1 to 4 carbon atoms) , a linear or branched alkyl group
having 1 to 4 carbon atoms, a hydroxyl group or a ring formed
of A2 and A3:
22
CA 02644665 2008-09-03
R'
R2~( - X \
II A +
p /m
HO p Al
A2
HO [ A3
A4
<28> In the above item <27>, the B) ligand may be
represented by following general formula Ia:
Ri
I ~.
R z
-0~ n ~ m Ia
HO 0 A~
Az
HO ~ A3
A4
<29> In the above item <2~>, the B) ligand may be
represented by following general formula Ib:
Ri
R 2
X-~ ~n.
p ~ m Ib
HO ~ A,
A2
HO ( A3
A4
<30> In any one of the above items <27> to <29>, the A)
metal alkoxide or metal amide and B) ligand may be 1:1 to 1:4
by molar ratio of A:B.
23
CA 02644665 2008-09-03
<31> In any one of the above items <27> to <30>, the rare
earth metal may be ytterbium, yttrium, lanthanum, cerium,
praseodymium, samarium, europium, gadolinium, dysprosium,
holmium or erbium.
<32> In any one of the above items <27> to <31>, an alkyl
group of the trialkylsilyl group may be a linear or branched
alkyl having 1 to 4 carbon atoms.
<33> In any one of the above items <27> to <32>, the A)
metal alkoxide ormetal amidemaybe gadoliniumtriisopropoxide,
yttrium triisopropoxide,
tris-[N,N-bis(trimethylsilyl)amide]gadolinium (III),
tris-[N,N-bis(trimethylsilyl)amide]yttrium (III) or barium
di.isopropoxide.
<34> In any one of the above items <27> to <33>, n may
be an integer of 0 or 1, and preferably 0.
<35> In any one of the above items <27> to <34>, m may
be an integer of 2 to 4, and preferably 2 or 3.
<36> In any one of the above items <27> to <35>, two of
the A1 to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<Cl> A ligand represented by the above-described general
formula Ia, wherein each of R1 and R2 independently represents
0 to 5 substituent groups; X represents P, As or N; m represents
an integer of 0 to 7; n represents an integer of 0 to 3; and
each of A1 to A4 independently represents a hydrogen atom, a
fluorine atom, a chlorine atom, a bromine atom, a benzoyl group,
24
CA 02644665 2008-09-03
an acetyl group, or a ring formed of A2 and A3.
<C2> In the above item <Cl>, n may be an integer of 0
or 1, and preferably 0.
<C3> In the above item <Cl> or <C2>, m may be an integer
of 2 to 4, and preferably 2 or 3.
<C4> In any one of the above items <C1> to <C3>, two of
the Al to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably Al and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<C5> A method of producing a ligand represented by the
above-described general formula Ia (wherein each of R' and R2
independently represents 0 to 5 substituent groups; X represents
P, As or N; m represents an integer of 0 to 7; n represents an
integer of 0 to 3; and each of A1 to A4 independently represents
a hydrogen atom, a fluorine atom, a chlorine atom, a bromine
atom, a benzoyl group, an acetyl group, or a ring formed of A2
andA3) froma compound representedbythe above-described general
formula IIa (wherein R3 represents a hydrogen atom, a linear
or branched alkyl group having 1 to 8 carbon atoms, a linear
or branched alkenyl group having 2 to 8 carbon atoms, a benzyl
group, a paramethoxy benzyl group or a silyl group; m has the
same definition as described above; and each of A1 to A4
independently has the same definition as described above);
the method comprising the steps of:
a) reacting the compound represented by the general f ormula
IIa with a metal salt of diphenylphosphine, diarylphosphine or
diarylamine;
CA 02644665 2008-09-03
b) thereafter, processing with ammonium chloride and
hydrogen peroxide; and
b' ) when X is As or N and R3 is one other than a hydrogen
atom, allowing palladium-carbon to react with hydrogen, lithium
chloride, dichlorodicyanobenzoquinone, cerium ammonium nitrate
or a fluorine anion (for example, a fluorine anion derived from
tetrabutylammonium fluoride) to make the R3 a hydrogen atom,
to obtain the ligand represented by the general formula Ia.
<C6> In the above item <C5>, the compound represented
bythe general formula IIamaybe obtainedby c) reacting a compound
represented by the above-described generalformulaIlIa,wherein
m has the same definition as described above, in the presence
of diethylazodicarboxylate or diisopropylazodicarboxylate and
triphenylphosphine or tributylphosphine, with a compound
represented by the above-described general formula IV, wherein
R3 and A1 to A4 have the same definitions as described above.
<C7> In the above item <C6>, the compound represented
by the general formula IIIa may be obtained by d) reacting a
compound represented by the above-described general formula Va,
wherein m has the same definition as described above, in the
presence of a phosphoric acid buffer, with a peracid (such as
3-chloroperbenzoic acid, perbenzoic acid, peracetic acid or
hydrogen peroxide,in particular,3-chloroperbenzoic acid being
preferred).
<C8> In any one of the above items <C5> to <C7>, n may
be an integer of 0 or 1, and preferably 0.
<C9> In any one of the above items <C5> to <C8>, m may
26
CA 02644665 2008-09-03
be an integer of 2 to 4, and preferably 2 or 3.
<C10> In any one of the above items <C5> to <C9>, two of
the A1 to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<C11> In any one of the above items <C5> to <C9>, R3 may
be a methyl group.
<C12> A method of producing a ligand represented by the
above-described general formula Ia (wherein each of R' and R2
independently represents 0 to 5 substituent groups; X represents
P, As or N; m represents an integer of 0 to 7; n represents an
integer of 0 to 3; and each of Al to A4 independently represents
a hydrogen atom, a fluorine atom, a chlorine atom, a bromine
atom, a benzoyl group, an acetyl group, or a ring formed of A2
andA3) from a compound represented by the above-described general
formula IIa (wherein R3 represents a hydrogen atom, a linear
or branched alkyl group having 1 to 8 carbon atoms, a linear
or branched alkenyl group having 2 to 8 carbon atoms, a benzyl
group, a paramethoxy benzyl group or a silyl group; m has the
same definition as described above; and each of A1 to A4
independently has the same definition as described above);
the method comprising the steps of:
g) reacting a compound represented by the general formula
IIa with diethylaluminum cyanide, followed by reacting with
concentrated hydrochloric acid, to obtain a compound represented
by the above-described general formula VIIa, wherein m, R3 and
A1 to A4 have the same definitions as described above;
27
CA 02644665 2008-09-03
h) reacting the compound represented by the general formula
VIIa with BH3, to obtain a compound represented by the
above-described general formula VIIIa, wherein m, R3 and A1 to
A4 have the same definitions as described above;
j) reacting the compoundrepresented by thegeneralformula
VIIIa with p-toluenesulfonyl chloride, to obtain a compound
represented by following general formula IXa, wherein Ts
represents a p-toluenesulfonyl group, and m, R3 and A1 to A4 have
the same definitions as described above;
k) reacting the compound representedbythe general formula
IXa with potassium diphenyl phosphide, f ollowed by reacting with
hydrogen peroxide, to obtain a compound represented by the
above-described general formula Xa, wherein m, R3 and A1 to A4
have the same definitions as described above; and
1) reacting the compound represented by the general formula
Xa with lithium iodide, to obtain the ligand represented by the
general formula Ia.
<C13> In the above item <C12>, n may be an integer of 0
or 1, and preferably 0.
<C14> In the above item <C12> or <C13>, m may be an integer
of 2 to 4, and preferably 2 or 3.
<C15> In any one of the above items <C12> to <C14>, two
of the Al to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
<C16> In any one of the above items <C12> to <C15>, R3
may be a methyl group.
28
CA 02644665 2008-09-03
<C17> A catalyst being formed of:
A) a metal alkoxide or a metal amide represented by MX (0R4) Y
or MX,(NR5)y-, wherein M is a metal selected from the group
consisting of titanium, zirconium, aluminum, gallium and rare
earth elements; each of R4 and R5 independently represents a
substituted or non-substituted, linear or branched or cyclic
alkyl group having 2 to 6 carbon atoms, a substituted or
non-substituted, linear or branched or cyclic alkenyl group,
a substituted or non-substituted aromatic group or a
trialkylsilyl group, and x and y and x' and y' are integers
stoichiometrically determined by the metal M; and
B) a ligand represented by the above-described general
formula Ia, wherein each of R1 and R2 independently represents
0 to 5 substituent groups; X represents P, As or N; m represents
an integer of 0 to 7; n represents an integer of 0 to 3; and
each of A1 to A4 independently represents a hydrogen atom, a
fluorine atom, a chlorine atom, a bromine atom, a benzoyl group,
an acetyl group or a ring formed of A2 and A3.
<C18> In the above item <C17>, the A) metal alkoxide or
metal amide and B) ligand may be l:l to 1:4 by molar ratio of
A:B.
<C19> In the above item <C17> or <C18>, the rare earth
metalmay be ytterbium, yttrium, lanthanum, cerium, praseodymium,
samarium, europium, gadolinium, dysprosium, holmium or erbium.
<C20> In any one of the above items <C17> to <C19>, an
alkyl group of the trialkylsilyl group may be a linear or branched
alkyl having 1 to 4 carbon atoms.
29
CA 02644665 2008-09-03
<C21> In any one of the above items <C17> to <C20>, the
A) metal alkoxide or metal amide may be gadolinium
triisopropoxide, yttrium triisopropoxide,
tris-[N,N-bis(trimethylsilyl)amide]gadolinium (III), or
tris-[N,N-bis(trimethylsilyl)amide]yttrium (III).
<C22> In any one of the above items <C17> to <C21>, n may
be an integer of 0 or 1, and preferably 0.
<C23> In any one of the above items <C17> to <C22>, m may
be an integer of 2 to 4, and preferably 2 or 3.
<C24> In any one of the above items <C17> to <C23>, two
of the Al to A4 may be hydrogen atoms and the other two thereof
may be fluorine atoms, preferably A1 and A4 may be hydrogen atoms
and A2 and A3 may be fluorine atoms.
Effects of the invention
The present invention can provide a novel asymmetric ligand
that is synthesized by a short production process at low cost
and a producing method thereof, and a catalyst using the novel
ligand.
Further, other than or in addition to the above-described
effects, the present invention can provide a novel asymmetric
ligand that is capable of developing the catalyst activity and
enantioselectivity higher than that of a conventional
glucose-derived ligand and a producing method thereof, and a
catalyst using the novel ligand.
In particular, the present invention can provide, in a
catalytically asymmetric ring opening reaction in a cyano group
CA 02644665 2008-09-03
of aziridine, which is useful for synthesizing an optically
active (3-amino acid, a novel asymmetric ligand that is capable
of developing functions such as catalyst activity and
enantioselectivity excellent more than that of a conventional
glucose-derived ligand and a producing method thereof, and a
catalyst using the novel ligand.
Best mode for carrying out the present invention
The present invention will be described in detail
hereinafter.
The present invention provides a novel asymmetric ligand.
<Asymmetric Ligand>
A ligand according to the present invention may be
represented by a formula I or Ia or Ib shown below (hereinafter,
in some cases, formulas I, Ia and Ib are abbreviated as "formula
I or the like") . In the formulas, each of R1 and R2 independently
represents 0 to 5 substituent groups; X represents P, As or N;
m represents an integer of 0 to 7; n represents an integer of
0 to 3; and each of A1 to A4 independently represents a hydrogen
atom, a fluorine atom, a chlorine atom, a bromine atom, a benzoyl
group, an acetyl group, a nitro group, a trifluoroacetyl group,
a trifluoromethyl group, an alkoxy group represented by -ORa
(Ra represents a linear or branched alkyl group having 1 to 4
carbon atoms), an amino group represented by -NRbRc (each of
Rb and Rc independently represents a hydrogen atom or a linear
or branched alkyl group having 1 to 4 carbon atoms) , a linear
or branched alkyl group having 1 to 4 carbon atoms, a hydroxyl
31
CA 02644665 2008-09-03
group or a ring formed of A2 and A3.
As can be seen from the formula I or the like, the ligand
according to the present invention is different from a
conventional ligand of which mother nucleus is derived from
glucose (such as Japanese Patent No. 3671209) . The ligand
according to the present invention, which is different in a
structure from that of a conventional ligand, has a function
such as described below. For instance, according to the ligand
of the present invention, a catalyst using the ligand has high
catalyst activity and/or high enantioselectivity.
R'
R 2
0 n )m I
HO O Ai
A2
HO [ A3
A4
Ri
R2~( ~~~--X
II n
o )m Ia
HO~ A
O
A2
HO [ A3
A4
Ri
2
R >-X~ ~ m
11 n
O Ib
A2
HO 6
HO f ~ A3
A4
32
CA 02644665 2008-09-03
In the formulas, n may be an integer of 0 or 1, preferably
0; m may be an integer of 2 to 4 and preferably 2 or 3; and X
may be P or N, preferably P.
Among A1 to A4, preferably two may be hydrogen atoms, and
the other two may be fluorine atoms, and more preferably A1 and
A4 may be hydrogen atoms and A2 and A3 may be fluorine atoms.
<Method of preparing Asymmetric Ligand>
An asymmetric ligand according to the present invention
may be prepared:
From a compound represented by the formulas II or the like
(the phrase "the formula II or the like" used herein means a
formula II, IIa or IIb, and, hereinafter, in some cases, simply
abbreviated as "formula II or the like") , a ligand represented
by the formula I or the like may be prepared. The method comprises
the step of:
a) reacting a compound represented by the formula II or
the like with a metal salt of diphenylphosphine, a metal salt
of diarylphosphine or a metal salt of diarylamine;
b) thereafter processing with ammonium chloride and
hydrogen peroxide; and
b' ) when X is As or N and R3 is other than a hydrogen atom,
allowing palladium-carbon to react with hydrogen, lithium
chloride, dichlorodicyanobenzoquinone, cerium ammonium nitrate
or a fluorine anion (such as fluorine anion derived from
tetrabutylammonium fluoride) to make R3 a hydrogen atom.
Herein, in the formula II or the like, R3 represents a
hydrogen atom, a linear or branched alkyl group having 1 to 8
33
CA 02644665 2008-09-03
carbon atoms, a linear or branched alkenyl group having 2 to
8 carbon atoms, a benzyl group, a paramethoxybenzyl group or
a silyl group. R3 preferably represents a methyl group or a
benzyl group and more preferably a methyl group. In the formula
II or the like, m and Al to A4 have same definitions as described
above.
The step a) , depending on compounds used, may be carried
out by use of a solvent such as tetrahydrofuran (hereinafter,
abbreviated as "THF"), ethers or dioxane under conditions of
-78 to 50 C.
Further, the step b), depending on compounds used, may
be carried out by use of a solvent such as THF, ethers or dioxane
under conditions of -20 to 20 C.
More, the step b'), depending on compounds used, may be
carried out by use of a solvent such as THF, ethers, dioxane,
methylene chloride, dimethyl formamide, or dimethyl sulfoxide
under conditions of -78 to 50 C.
The producing method that has the steps a) and b) (and
step b' ) ) is preferred when one where n is zero in the formula
I is obtained and in less steps.
Further, a compound represented by the formula II or the
like is prepared as follows:
c) Reating a compound represented by the formula III or
the like (Herein, "the formula III or the like" means formula
III, IIIa or IIIb. Hereinafter, in some cases, these are simply
abbreviated to as "formula III or the like") , under the presence
of diethylazodicarboxylate or diisopropylazodicarboxylate and
34
CA 02644665 2008-09-03
triphenyl phosphine or tributyl phosphine, preferably under the
presence of diisopropylazodicarboxylate, with a compound
represented by the formula IV can obtain a compound represented
by the formula II or the like. In the formula III or the like
and IV, m, R3 and A1 to A4 have the same definitions as described
above.
The step c) , depending on compounds used, may be carried
out by use of a solvent such as THF, ethers, or dioxane under
conditions of 0 to 50 C.
Further, a compound represented by the formula III or the
like is prepared as follows:
d) Reacting a compound represented by the formula V or
the like (Herein, "the formula V or the like" means formulas
V, Va or Vb. Hereinafter, in some cases, these are simply
abbreviated as "formula V or the like") , under the presence of
a phosphoric acid buffer, with a peracid (such as
3-chloroperbenzoic acid, perbenzoic acid, peracetic acid or
hydrogen peroxide, 3-chloroperbenzoic acid being particularly
preferred) can obtain a compound represented by the formula III
or the like . In the formula V or the like, mhas the same definition
as described above.
The step d) , depending on compounds used, may be carried
out by use of a solvent such as methylene chloride, chloroform,
ethers or dioxane under conditions of -20 to 20 C.
More, a ligand according to the present invention may be
produced from a compound represented by the formula II or the
like through a route different from the above-mentioned ones.
CA 02644665 2008-09-03
The method may comprise the steps of:
g) reacting the compoundrepresented by the general formula
II or the like with diethylaluminum cyanide, followedby reacting
with concentrated hydrochloric acid, to obtain a compound
represented by the formula VII or the like (the term "the formula
VII or the like" used herein means a formula VII, VIIa or VIIb.
Hereinafter, in some cases, these are simply abbreviated as "the
formula VII or the like");
h) reacting the compound represented bythe general formula
VII or the like with a BH3 tetrahydrofuran complex, a BH3
dimethylsulfide complex or LiAlH4r to obtain a compound
represented by the formula VIII or the like (the term "the formula
VIII or the like" used herein means a formula VIII, VIIIa or
VIIIb. Hereinafter, insomecases, these are simply abbreviated
as "the formula VIII or the like");
j) reacting the compound represented by the formula VIII
or the like with p-toluenesulfonylchloride,to obtain a compound
represented by the formula IX or the like (the term "the formula
IX or the like" used herein means a formula IX, IX a or IX b.
Hereinafter, in some cases, these are simply abbreviated as "the
formula IX or the like");
k) reacting the compound represented by the formula IX
or the like with potassium diphenyl phosphide, followed by
reacting with hydrogen peroxide, to obtain a compound represented
by the formula X or the like (the term "the formula X or the
like" used herein means a formula X, X a or X b. Hereinafter,
in some cases, these are simply abbreviated as "the formula X
36
CA 02644665 2008-09-03
or the like"); and
1) reacting the compound representedby the generalformula
X with lithium iodide, to obtain the ligand represented by the
formula I or the like.
In the formulae VII or the like, VIII or the like, IX or
the like andX or the like, m, R3 andAl toA4 have the same definitions
as described above. Further, in the formula IX or the like,
Ts represents p-toluenesulfonyl group.
The step g) , depending on compounds used, may be carried
out by use of a solvent such as THF, ethers, dioxane or toluene
under conditions of -20 to 100 C.
The step h) , depending on compounds used, may be carried
out by use of a solvent such as THF, ethers, dioxane or toluene
under conditions of -20 to 20 C.
The step j), depending on compounds used, may be carried
out by use of a solvent such as methylene chloride or pyridine
under conditions of -78 to 50 C.
The step k) , depending on compounds used, may be carried
out by use of a solvent such as THF, ethers, dioxane or toluene
under conditions of -78 to 50 C.
The step 1) , depending on compounds used, may be carried
out by use of a solvent such as dimethyl formamide or dimethyl
sulfoxide under conditions of -78 to 200 C.
<Catalyst>
The present invention provides a catalyst using the
above-described asymmetric ligand.
A catalyst according to the present invention is formed
37
CA 02644665 2008-09-03
of a metal alkoxide or a metal amide represented by A) MX (OR4) Y
or MX, (NR5) y= ; and B) a ligand represented by the formula I.
Herein, M is a metal selected from a group of titanium,
zirconium, aluminum, gallium, barium and rare earth elements.
Each of R4 and R5 independently represents a substituted or
non-substitutedlinear or branched or cyclic alkyl group having
2 to 6 carbon atoms, a substituted or non-substituted linear
or branched or cyclic alkenyl group, a substituted or
non-substituted aromatic group or a trialkylsilyl group, wherein
x and y and x' and y' are integers determined stoichiometrically
by the metal M. An alkyl group of the trialkylsilyl group may
be a linear or branched alkyl having 1 to 4 carbon atoms.
Among the M, preferable examples of the rare earth metals
may include ytterbium, yttrium, lanthanum, cerium, praseodymium,
samarium, europium, gadolinium, dysprosium, holmium and erbium.
The M is particularly preferably gadolinium or yttrium.
Preferable examples of A) metal alkoxides or metal amides
may include gadolinium triisopropoxide, yttrium
triisopropoxide,
tris-[N,N-bis(trimethylsilyl)amide]gadolinium (III) and
tris-[N,N-bis(trimethylsilyl)amide]yttrium (III).
Furthermore, A) metal alkoxide or metal amide is preferably
barium diisopropoxide.
Herein, "being formed of" means a state including all of
i) a case where both of the A component and B component work
as a catalyst, ii) a case where OR4 or OR5 of the A component
is partially or entirely substituted by a ligand of the B component
38
CA 02644665 2008-09-03
to work as a catalyst, and iii) a case where both states of the
i) and ii) are present and work as a catalyst.
In the A) metal alkoxide or metal amide and B) ligand,
a mole ratio of A: B is 1:1 to 1:4 and preferably 1:1 to 1:2.
Such a catalyst may be prepared as shown below: Mixing
the A component and B component in THF or propionitrile such
that the mixture is in the above-described mole ratio, followed
by reacting the mixture at a temperature from room temperature
to 80 C can obtain the catalyst.
The present invention will be illustrated in more detail
by way of, but is not limited to the following examples.
Furthermore, Fig.lshowsaschemesurveyingfollowingexamples.
EXAMPLE 1:
3-Chloroperbenzoic acid
Phosphoric acid buffer
I (pH=7. 2 ) 0;%,
,
= C H2C12, 0 C =
OH 91% OH
Optically active allylalcohol (see Lussem, B.J.; Gais,
H.-J. J. Am. Chem. Soc. 2003, 125, 6066, 100 mg, 0.968 mmol)
was dissolved in methylene chloride (10 mL) and a phosphoric
acid buffer (2 mL), followed by, under ice-cooling, adding
3-chloroperbenzoic acid (0.34g, 0.968 mmol) . After stirring
for 1 hr, sodium sulfate was added and a reaction soluti_on was
purified directly by means of alumina column chromatography
(eluting solvent =methylene chloride -+ ethyl acetate) to obtain
39
CA 02644665 2008-09-03
a target subject, epoxy alcohol (0.34 g, yield: 910).
NMR (CDCL3) b 1.21-1.31 (1H, m), 1.41-1.49 (1H, m), 1.51-1.60
(2H, m), 1.75-1.81 (1H, m), 1.84-1.90 (1H, m), 1.98 (1H, brs),
3. 31 (1H, t, J= 3. 7 Hz ), 3. 34 (1H, t, J= 3. 7 Hz ), 4. 00 (1H, brs )
EXAMPLE 2:
PPh3
0 diisopropylazodicarboxylate 0;;;
(DIAD)
HO \ F O I~ F
OH I/ THF, rt, 89% MeO ~ F
Me0 F
To a solution of triphenyl phosphine (1.12 g, 4.27 mmol)
and monomethylfluorocatecol (684 mg, 4.27 mmol) in
tetrahydrofuran (hereinafter, simply abbreviated as "THF") (5
mL), a solution (1 mL) of diisopropylazodicarboxylate (DIAD)
(840 mL, 4.27 mmol) and epoxy alcohol (325 mg, 2.85 mmol) in
THF was added under ice-cooling. After reacting the mixture
at room temperature for 18 hr, the mixture was diluted with ethyl
acetate, followed by washing an organic layer with water and
a saturated saline solution. The organic layer was dried over
sodium sulfate, filtered and concentrated. A resulting crude
product was purified by use of silica gel column chromatography
(ethyl acetate: hexane =1: 5), thereby to obtain a target product,
epoxy ether (649 mg, yield: 890).
NMR (CDCL3) b 1.24-1.33 (1H, m), 1.40-1.48 (1H, m), 1.51-1.57
(1H, m), 1.78-1.85 (1H, m), 1.89-1.95 (1H, m), 2.04-2.10 (1H,
m), 3.22 (1H, d, J=3.5 Hz), 3.26-3.28 (1H, m), 4.36 (1H, dd,
CA 02644665 2008-09-03
J=9. 0 , 5.5 Hz) , 6.73 (1H, dd, J=12, 7.7 Hz) , 6. 86 (1H, dd, J=12, 7.7
Hz) .
EXAMPLE 3:
O
11
Ph-P
O"' Ph
1) LiPPh2
2) H202 HO~,
O ~ F O F
~ 88% \
//ll
Me0 ~ F HO ~ F
Epoxy ether (1.50 g, 5.85 mmol) was dissolved in THF (20
mL), followed by adding diphenyl phosphine (3 mL, 17.6 mmol)
and BuLi (1.6 M in hexane, 10 mL, 17.6 mmol) at -78 C to react
the mixture for 20 min. Thereafter, after stirring at room
temperature for 15 hr, a saturated ammonium chloride aqueous
solution was added. The resulting solution was ice-cooled,
followed by adding hydrogen peroxide water (5 mL) and stirring
for 30 min, further followed by adding a saturated sodium
thiosulfate aqueous solution. A resulting product was
extracted with ethyl acetate, followed by washing an organic
layer with a saturated saline solution. The organic layer was
dried over sodium sulfate, followed by filtering and
concentrating. A resulting product was subjected to silica gel
column chromatography (ethyl acetate: hexane = 1: 1-> 2: 1) to
obtain a target subject, phosphine oxide (2.29 g, yield: 88%) .
The resulting crystal was recrystallized from isopropyl alcohol
to obtain an asymmetric ligand having 100% optical purity. The
optical purity of the ligand was confirmed by use of the optically
41
CA 02644665 2008-09-03
active HPLC (trade name: CHIRALCEL-ODH, produced by Daicel,
isopropyl alcohol:hexane = 1: 9, flow rate: 1.0 mL/min, tR = 6.8
min (minor: not observed), 9.5 min (major)).
NMR (CDCL3) b 1.0-1.1 (1H, m), 1.30-1.38 (1H, m), 1.40-1.50 (1H,
m) , 1. 68-1. 83 (2H, m) , 2. 15-2. 22 (1H, m) , 2. 66 (1H, m) , 3.58-3. 63
(1H, m), 3.98-4.04 (1H, m), 3.58-3.64 (1H, m), 3.98-4.04 (1H,
m), 6.73-6.79 (2H, m), 6.88 (1H, brs), 7.50-7.57 (4H, m),
7.58-7.66 (2H, m), 7.71-7.78 (4H, m).
EXAMPLE 4:
NC
Et2CN HO'_
O ~ F - O ~ F
/~ EtzO 71 % ~
MeO ~ F MeO ~ F
Epoxy ether (100 mg, 0.390 mmol) was dissolved in diethyl
ether (3.9mL),followed by adding diethyl aluminum cyanide (1.0
M in toluene, 470 mL, 0.585 mmol) at 0 C to react the mixture
for 3 hr, further followed by adding a saturated sodium chloride
aqueous solution. Thereto, a saturated Rochelle salt aqueous
solution was added, followed by stirring for 1 hr. A product
was extracted with ethyl acetate and an organic layer was washed
with a saturated saline solution. The organic layer was dried
over sodium sulfate, followed by filtering and concentrating,
further followed by subjecting a resulting product to silica
gel column chromatography (ethyl acetate: hexane =5:2), thereby
to obtain a target object, cyanohydrin (80 mg, yield: 730).
NMR (CDCL3) 51.24-1.34 (1H, m), 1.48-1.56 (1H, m), 1.64 (1H,
42
CA 02644665 2008-09-03
m) , l. 82-1. 88 (1H, m) , 2. 07-2. 18 (2H, m) , 2. 50 (1H, ddd, J= 13,
10, 3.7 Hz), 3.78-3.82 (1H, m), 3.83 (3H, s), 4.02 (1H, brs),
6.75 (1H, dd, J=12,7.6 Hz), 6.85 (1H, dd, J=12, 7.6 Hz).
EXAMPLE 5:
NC H02C
HO'_ HCI HO'
O\/F O F
~"'I \ 93% I ~
MeO//~~F MeO ~ F
Cyanohydrin (196mg, 0. 691 mmol ) was dissolved indimethoxy
ethane (15 mL), followed by adding 12N hydrochloric acid (15
mL) and reacting the mixture at 85 C for 24 hr. A resulting
product was extracted with ethyl acetate, followed by washing
an organic layer with a saturated saline solution. The organic
layer was dried over sodiumsulfate, filtered and concentrated.
A resulting product was dissolved in 3N sodium hydroxide aqueous
solution (1 mL), followed by washing with diethyl ether. To
a resulting product, 1N hydrochloric acid was added, followed
by extracting with ethyl acetate, an organic layer was dried
over sodium sulfate, filtered and concentrated, therebytoobtain
a target subject, hydroxycarboxylic acid(374mg, yield:quant).
NMR (CDCL3) b 1.28-1.37 (1H, m), 1.46-1.60 (1H, m), 1.84-1.90
(1H, m), 2.08-2.14 (1H, m), 2.15-2.21 (1H, m), 2.43 (1H, ddd,
J=12.5, 10.5, 4.3 Hz) , 3.68 (1H, ddd, J=11.3, 8.6, 4. 9 Hz) , 3.85
(3H, s), 3.93 (1H, dd, J=10.7, 8.9 Hz), 6.76 (1H, dd, J= 11.3,
7.7 Hz), 6.89 (1H, dd, J= 10.7, 7.9 Hz).
43
CA 02644665 2008-09-03
EXAMPLE 6:
HOzC
HO
HO"BH3= THF HO
0
~ F -- O ~ F
~ THF quant. I
MeO ~ F / ~% \
Me0 F
Hydroxycarboxylic acid (295mg, 0.976mmo1) was dissolved
in THF (5mL),followed by adding borane tetrahydrofuran complex
(1.17 M in THF, 3.34 mL, 3.90 mmol) to react the mixture for
2 hr. Thereafter, 1N hydrochloric acid was added, followed by
adding a saturated sodium hydrogen carbonate aqueous solution.
A product was extracted with ethyl acetate, followed by washing
an organic layer with a saturated saline solution, further
followed by drying over sodium sulfate, filtering and
concentrating. A resulting product was subjected to silica gel
column chromatography (ethyl acetate: hexane = 2: 3), thereby
to obtain a target object, diol (281 mg, yield: quant) . The
resulting crystal was recrystallized from methylene chloride
and hexaneto obtain diolhaving100oopticalpurity. Theoptical
purity of the diol body was confirmed by use of the optically
active HPLC (trade name: CHIRALCEL-ADH, produced by Daicel,
isopropyl alcohol:hexane = 1:9, flow rate: 1.0 mL/min, tR= 12.2
min (major), 14.9 min (minor: not observed)).
NMR (CDCL3) 5 1.05 (1H, ddd, J= 26.3, 13.1, 3.7 Hz), 1.28-1.38
(1H, m), 1.42-1.51 (1H, m), 1.60-1.74 (2H, m), 1.77-1.82 (1H,
m), 2.11-2.17 (1H, m), 3.62-3.75 (4H, m), 3.84 (3H, s), 3.91
(1H, brs), 6.74 (1H, dd, J= 11.0, 8.0 Hz).
44
CA 02644665 2008-09-03
EXAMPLE 7:
HO Ts0
HO' TsCI, TEA HO'O
DMAP, CH2CI2
Me0 F quant.
Me0 F
Diol (38 mg, 0.132 mmol) was dissolved in methylene
chloride (1.3 mL), followed by adding triethyl amine (37 mL),
N.N-dimethylamino pyridine and tosylchloride to react the
mixture at room temperature for 6 hr. Thereto, 1N hydrochloric
acid was added, followed by extracting a product with ethyl
acetate, further followed by washing an organic layer with a
saturated sodium hydrogen carbonate aqueous solution and a
saturated saline solution. The organic layer was dried over
sodium sulfate, filtered and concentrated, to obtain a target
object, tosylate (58 mg, yield: quant).
NMR (CDCL3) b 0.87-0.92 (1H, m), 1.21-1.26 (1H, m), 1.41-1.48
(1H, m), 1.70-1.80 (3H, m), 2.07-2.13 (1H, m), 2.45 (3H, s),
3.40 (1H, s), 3.50 (1H, t, J= 9.5 Hz), 3.61-3.66 (1H, m), 4.16
(1H, dd, J= 9.5, 6.1 Hz), 4.22 (1H, dd, J= 9.5, 3.1 Hz), 6.73
(1H, dd, J= 11.0, 7.3 Hz) , 6.84 (1H, dd, J= 11. 0, 7. 9 Hz) , 7.34
(2H, d, J= 7. 9 Hz) , 7.81 (2H, d, J= 8.3 Hz)
EXAMPLE 8:
CA 02644665 2008-09-03
O
Ts0
1) KPPh2 P Ph
HO' 2) H2O2 HO'
O I~F /~~ F 3) Li DMF
Me0 O F
~\%~ 81% I
HO F
Tosylate (86.3 mg, 0.195 mmol) was dissolved in THF (1
mL) , followed by adding potassium diphenyl phosphide (0. 5 M in
THF, 858mL, 0. 429 mmol ) under ice cooling to reacting the mixture
for15min. Thereafter, hydrogenperoxidewater (5mL) was added,
followed by stirring for 30 min, further followed by adding a
saturatedsodiumthiosulfate aqueous solution. After a product
was extracted with ethyl acetate, an organic layer was washed
with saturated saline solution. The organic layer was dried
over sodium sulfate, filtered and concentrated, toobtain a crude
product.
The resulting crude product was dissolved in DMF (1 mL) ,
thereto lithium iodide (157 mg, 1.17 mmol) was added, followed
by reacting the mixture at 160 C for 19 hr. After adding water
thereto, a product was extracted with ethyl acetate. An organic
layer was washed with saturated saline solution, followed by
drying over sodium sulfate, further followed by filtering and
concentrating, to obtain a target object, phosphine oxide (74.1
mg, yield: 810).
NMR (CDCL3) b 1.10-1.19 (1H, m), 1.26-1.35 (2H, m), 1.48-1.57
(1H, m), 1.67-1.80 (2H, m), 2.13-2.18 (1H, m), 2.39-2.44 (2H,
m), 3.31-3.37 (1H, m), 3.56 (1H, t, J= 9.2 Hz), 6.72 (1H, dd,
J= 11. 6, 8. 0 Hz) , 6.78 (1H, dd, J= 10.7, 8.3 Hz) , 7.46-7.60 (6H,
m), 7.69-7.78 (5H, m).
46
CA 02644665 2008-09-03
EXAMPLE 9:
O. Gd(O'Pr)3 (2 moI %)-ligand (3 mol %) H
aN ~ TMSCN (3 equiv) N 2dethphenol (1 equiv) 2 THF, rt. 78a (R,R)-19a
<Aziridine Ring Opening Reaction>
An asymmetric ligand obtained in Example 3 (in Table 1
below, represented by "4" of "ligand", simply represented as
"ligand" in the formula) (13.3 mg, 0.03 mmol) was dissolved in
0.6 mL of THF, Gd (O1Pr) 3(0.2 M in THF, 100 L, 0.02 mmol) was
added thereto, followed by stirring at 54 C for 1 hr. The solvent
was distilled away, followed by drying a residue under reduced
pressure by use of a vacuum pump for 2 hr. Thereto, aziridine
18a that is a rawmaterial (246mg, 1. 0 mmol) , 2, 6-dimethyl phenol
(122 mg, 1. 0 mmol ) and THF (5 mL) were added, followed by further
adding 40 L of TMSCN (0.30 mmol) at room temperature. After
a reaction was carried out for 13 hr, water and ethyl acetate
were added to stop a reaction. A product was extracted with
ethyl acetate, a collected organic layer was dried over sodium
sulfate, followed by filtering and distilling away the solvent,
a resulting crude product was purified by use of a silica gel
column (hexane:ethyl acetate = 3:1 to 3:2), thereby to obtain
an aziridine ring opened body 19a at the yield of 99 0(269 mg,
0.99mmol). From the optically active HPLC analysis [Chiralpak
AD-H, 2-propanol/hexane 1/9, flow 1.0 mL/min, detection at 254
nm: tR 18. 4 min (major) and 2. 09 min (minor) ], the optical purity
was determined to be 98% ee. Example 9 is shown in Table 1 below
47
CA 02644665 2008-09-03
as "entry" No. "1".
19a: IR (KBr) : 3334, 3113, 2950, 2865, 2244, 1647, 1521, 1344,
877, 725 cm-1; 1H NMR (d-DMSO): b= 8.92 (d, J = 8.5 Hz, 1H),
8.35 (d, J = 9.0 Hz, 2H) , 8.06 (d, J = 9.0 Hz, 2H) , 4.12-3.97
(m, 1H), 2.86-2.75 (m, 1H), 2.17-2.06 (m, 1H), 1.91-1.81 (m,
1H), 1.77-1.55 (m, 3H), 1.44-1.27 (m, 2H), 1.25-1.12 (m, 1H);
13C NMR (d-DMSO) : 5 = 164.0, 149.1, 139.8, 128.7, 123.7, 121.3,
49.7, 33. 8, 31.7, 28.8, 23.9, 23.8; MS (ESI) : m/z 296 [M+Na+] ;
Anal. calcd for C19H25N3O3: C, 61.53; H, 5.53; N, 15. 38 0. Found:
C, 61 . 13; H, 5.61; N, 15. 21 0; [a] 22D -72 .5 ( c= 0. 350, Acetone)
(>99% ee).
EXAMPLES 10 to 19:
Except that, in place of a ligand in the example 9, a ligand
represented by "5" in Table 1 below was used and/or in place
of a raw material aziridine 18a in the example 9, each of 18b
to 18i was used, an aziridine ring opening reaction was carried
out in a manner similar to example 9. Results thereof are shown
in Table 1 below. Examples 10 to 19, respectively, are shown
by "entry" Nos. "2", "4", "6", "8", "10", "11", "13", "15", "17"
and "19".
(COMPARATIVE EXAMPLES 1 to 9)
By use of a conventional ligand derived from glucose
(ligand represented by "1" in the table 1 below) in place of
the ligand in the example 9, a raw material aziridine 18a was
subj ected to a ring opening reaction in a manner similar to example
48
CA 02644665 2008-09-03
9. The result thereof is shown in "entry" No. "3" of Table 1.
Further, except that, in the comparative example 1, in
place of a raw material aziridine 18a, by use of each of 18b
to 18i, an aziridine ring opening reaction was carried out in
a manner similar to example 1. Results thereof are shown in
Table 1 below. Comparative examples 2 to 9, respectively, are
represented by "entry" Nos. "5", "7", "9", "12", "14", "16",
"18" and "20".
When examples and comparative examples that have the same
raw materials are compared, it is found that the optical purities
of examples (values represented by [ ee ( o)] in Table 1) are higher
than that of the comparative examples. From the foregoing
results, it was found that when the ligand according to the present
invention is used, in comparison with a conventional ligand
derived from glucose, a product is obtained with higher optical
purity.
49
CA 02644665 2008-09-03
Table l.
' 0 Gd(O'Pr)3 (x mol %)-ligand (1.5x mol %) H
R~ TMSCN (3 equiv) R~~NUAr
2,6-dimethylphenol (1 equiv) t
R" N / NO2 R ~ CN01
THF, temp.
18 (R,R)-19
entry substrate ligand loading temp. time yielda eeb
(x mol %) ( C) (h) (%) ("/o)
1 4 2 r.t 13 98 981
2 ~NR2 18a 5 1 40 3 99 99t
3d 1 10 0 20 94 879
4 ~ 4 2 40 12 83 96
5d ~ NR2 18b 1 10 r.t. 95 85 82
6 4 2 40 14 98 95
7d \ ~ NR2 18c 1 10 r.t. 42 91 83
8 4 2 40 14 98 98,
9d CDNR2 18d 1 10 40 14 98 919
4 2 40 22 99 96
11c CbzNa NR2 18e 5 2 40 74 99 96
12d 1 20 60 23 89 84
13 Z 4 2 60 28 84 96
14d Oa NR 18f 1 20 60 96 92 84
ONR2 5 67 15 99 95
16d 189 1 10 60 64 92 80
17 Me~ 4 2 40 14 98 98f
18 Me NR2 18h 1 10 r.t. 39 93 858
~ 2 181 4 5 67 4 95 (47/53)e 93/93
19 Ph N
20d Ph R 1 10 r.t. 96 81 (54/46)8 90/80
a Isolated yield.
b Determined by chiral HPLC.
c In the presence of 10 mol % of 2,6-dimethyiphenol at room temperature.
d Using a catalyst generated from 10 mol % of Gd(O'Pr)3 and 20 mol % of I in
the presence of 5 mol % of TFA and 1
equiv of 2,6-dimethylphenol in propionitrile at 0 C.
e Ratio of diastereomers determined by 1H NMR.
f Absolute configuration was determined as (R,R).
g Absolute configuration was determined as (S,S).
Ph h O Ph. Ph
p 1 O 4:XaF
u
S:X-H
0 0.
H O F H O X
I I
HQ F HO X
EXAMPLE 20:
<Cyano-Michael Addition Reaction>
CA 02644665 2008-09-03
Gd(O'Pr)3 (5 mol %)
Ligand 4 (7.5 mol %)
O TMSCN (1.5 equiv) CN O
~ N \ 2,6-Dimethyiphenol (1 equiv) )"I N
21a EtCN, -20 C 22a
An asymmetric ligand obtained in example 3 (in Table 1,
representedby"4" of "ligand") ( 6. 7 mg, 0. 015mmol) wasdissolved
in 0.3 mL of THF, Gd(01Pr)3 (0.2 M in THF, 50 L, 0.01 mmol)
was added at room temperature, followed by stirring at 54 C for
1 hr. A solvent was distilled away and a residue was dried under
reduced pressure by use of a vacuum pump for 2 hr. Thereto,
2, 6-dimethyl phenol (24. 4 mg, 0.2 mmol) was added, followed by
adding a raw material 21a (35.4 mg, 0.2 mmol) after dissolving
in 0.2 mL of THF. A reaction solution was cooled to -20 C and
TMSCN (40 mL, 0. 30 mmol) was added thereto. After 5. 5 hr, silica
gel was added to stop the reaction, followed by loading to a
silica gel column and eluting at hexane:ethyl acetate = 10:1
to 4:1 to purify, thereby 22a was obtained by 40.5 mg at the
yield of99o. From theoptically active HPLC analysis [Chiralcel
OD-H, 2-propanol/hexane 1/20, flow 1.0 mL/min, detection at 254
nm: tR 13. 0 min (minor) and 16. 7 min (major) ], the optical purity
was determined to be 93% ee. Example 20 is shown in Table 2
below as "entry" No. "1".
22a: IR (KBr) : 3402, 3145, 2960, 2931, 2242, 1708, 1474, 1374,
1292, 921 cm-1; 1H NMR (CDC13) : b= 7. 27 (brs, 2H) , 6. 32 (t, J
= 2. 3 Hz, 2H) , 3. 33-3. 16 (m, 2H) , 3. 06 (dd, J= 6. 1, 16. 7, 1H) ,
1.98-1.82 (m, 1H), 1.75-1.57 (m, 1H), 1.49-1.34 (m, 1H), 1.00
(d, J = 6.4 Hz, 3H), 0.99 (d, J = 6.7 Hz, 3H) ; 13C NMR (CDC13)
51
CA 02644665 2008-09-03
d = 166.5, 121.1, 118.8, 113.9, 40.8, 37.3, 26.2, 25.0, 22.9,
21.1; MS: m/z 204 [M+] ; Anal. calcd for C12H16N20: C, 70.56; H,
7.90; N, 13.71%. Found: C, 70.48; H, 8.03; N, 13.74%; [a]25D -
26.2 (c = 0.940, CHC13) (97% ee)
EXAMPLES 21 to 27:
Except that, in the example 20, an amount of Gd(OlPr)3
and an amount of the ligand were varied and/or, in place of the
raw material 21a in the example 20, each of 21b to 21h were used,
a cyano-Michael addition reaction was carried out in a manner
similar to example 9. The results thereof are shown in Table
2 below. In Table 2, examples 21 to 27, respectively, are shown
with "entry" Nos. "2", "4", "6", "8", "10", "12" and "14".
(COMPARATIVE EXAMPLES 10 to 16)
By use of a conventional ligand derived from glucose
(ligand represented by "1" in the table 1 and Table 2 below)
in place of the ligand in the example 20, a cyano-Michael addition
reaction was carried out with a raw material 21a in a manner
similar to example 20. The result thereof is shown in "entry"
No. "3" of Table 2.
Further, except that, in the comparative example 10, in
place of a raw material 21a, each of 21b to 21h was used, a
cyano-Michael addition reaction was carried out in a manner
similar to comparative example 10. Results thereof are shown
in Table 2 below. Comparative examples 11 to 16, respectively,
are shown by "entry" Nos. "5", "7", "9", "11", "13" and "15".
52
CA 02644665 2008-09-03
When examples and comparative examples that have the same
rawmaterials are compared, it is found that the optical purities
of examples (values represented by "ee ( o)" in Table 2) are equal
to or higher than that of the comparative examples. From the
foregoing results, it was found that when the ligand according
to the present invention is used, in comparison with a
conventional ligand derived from glucose, a product is obtained
with equal or higher optical purity.
53
CA 02644665 2008-09-03
Table 2.
Gd(O'Pr)3 (x mol %)
Ligand 4 (1.5x mol %) ~ TMSCN (1.5 equiv) C N ~
N0 2,6-Dimethylphenol (1 equiv) R^AN'~
21 EtCN, -20 C 22 v
entry substrate ligand x(mol h) time (h) yield (%)a ee (%)b
1 0 4 5 5.5 99 93d
2 'N \ 21a 4 2 14 99 93d
3c 1 5 42 89 97e
4 0 21 b 4 5 2.5 93 93d
,~ 1 5 42 91 98e
6 O~/ 4 5 2.5 95 96
7 -&'kN 21c 5 88 87 90
-D
8 21d 4 5 24 96 86
gc Ph N'~ 5 43 92 96
0 t"``/ 4 5 38 91 88d
lic N 21e 10 98 90 910
0 12 \ 21f 4 10 20 89 95
13 l 1 10 88 91 89
14 xO 4 5 1 92 (5.7/1) 76/12
(`r N \ 21h 1 5 8 99 (1.1/1) 88183
a Isolated yield.
b Determined by chiral HPLC.
c Using a catalyst generated from Gd(OlPr)3 and I in a 1:2 ratio with 0.5
equiv of TMSCN and 2 equiv of HCN.
d Absolute configuration was determined as shown in the scheme.
e Absolute configuration was opposite to the one shown in the scheme.
Ph O Ph. Ph
p 1 O' 4;X-F
O
O' O~
H 0 ~ F F{ O ~ X
I I
HO ~ F HO" ~ X
EXAMPLE 28:
<Conversion from 22a to Antiepileptic Agent Pregabalin>
54
CA 02644665 2008-09-03
C'" ~, ,, Pt02 (cat.) "iyHz
1 M NaOH ~N H2 (500 psi) ~COzH
N~ COZH
HCI, H20 _
22a 24 pregabalin
To a THF solution (0.44 mL) of a compound 22a (44.8 mg,
0.219 mmol) obtained in example 20, a 1 M NaOH aqueous solution
(0.44 mL) was added at room temperature. After 1 hr, THF was
distilled away under reduced pressure,thereto asaturatedsodium
hydrogen carbonate aqueous solution was added, followed by
washing an aqueous layer with methylene chloride three times.
The aqueous layer was controlled to pH = 1 by adding hydrochloric
acid and methylene chloride was used to extract. Organiclayers
were combined, followed by drying over sodium sulfate, further
followed by filtering and distilling away the solvent, thereby
to obtain 31.8 mg (940) of 24.
24: IR (neat): 2961, 2244, 1714, 1469, 1414, 1371, 1175, 924,
619 cm-1; 1H NMR (CDC13) : 5 = 9. 29 (brs, 1H), 3. 12-2 . 96 (m, 1H),
2.76 (dd, J= 7.5, 17.0 Hz, 1H), 2.62 (dd, J= 6.1, 17.0 Hz,
1H), 1.95-1.78 (m, 1H), 1.74-1.57 (m, 1H), 1.43-1.30 (m, 1H),
0.98 (d, J= 6. 7 Hz, 3H), 0.96 (d, J= 6. 7 Hz, 3H) ; 13C NMR (CDC13) :
^= 175.5, 120.8, 40.6, 36.8, 26.1, 25.5, 22.8, 21.2; MS: m/z
155 [M+] ; HRMS (EI ): m/z calcd for C8H19N02 [M+H+] : 156. 1025. Found:
156.1026; [a]21D -15.0 (c= 0.590, CHC13) . Observed value: [a]25D
-16.7 (c = 0.5, CHC13) (J. Am. Chem. Soc. 2003, 125, 4442)
The compound 24 obtained in the example is readily
converted to Pregabalin by reference to a prior literature (J.
Am. Chem. Soc. 2003, 125, 4442).
Thus, when by use of examples 20 and 28, intermediate bodies
CA 02644665 2008-09-03
are obtained at a smaller quantity of catalyst at a shorter time;
accordingly, a precursor 24 of an antiepileptic agent Pregabalin
is obtained efficiently more than ever.
EXAMPLE 29:
Except that, in example 2, monomethylchlorocatechol was
used in place of monomethyldifluorocatechol, an asymmetric
ligand where X = Cl in "ligand 2" of the following formula was
prepared in a manner similar to examples 1 to 3.
1H NMR (CDC13) : b= 9.28 (s, 1H), 7.74-7.70 (m, 4H), 7.62-7.47
(m, 6H), 7.03 (s, 1H), 6.98 (s, 1H), 6.84 (bs, 1H), 4.00 (dd,
J= 18. 6, 8. 5 Hz, 1H) , 3. 64-3. 59 (m, 1H) , 2. 64 (ddd, J= 22. 9,
12. 1, 3. 3 Hz, 1H) , 2. 19-2. 16 (m, 1H) , 1. 81-1. 69 (m, 2H) , 1. 48-1. 28
(m, 2H), 1.09-1.00 (m, 1H).
0
11
Ph-P
Ph~
HO"~
O X
I
Ligand 2 HO ~ X
EXAMPLE 30:
In a well-dried and argon-substituted test tube, an
asymmetric ligand (0. 02 mmol) prepared in example 3 was added,
followed by adding THF (0.323 mmol) . Thereto, 100 mL of a THF
solution of Ba (OPr) 2, left standing for 1 hr after the solution
was diluted to be 0. 2 M, was gradually added at room temperature.
After stirring at 50 C for 1 hr, the solvent was distilled away,
followed by drying under vacuum at room temperature for 3 hr.
56
CA 02644665 2008-09-03
A residual was dissolved in CH2C12 (300 mL) and cooled to -20 C.
Thereto, diene (52. 9 ml, 0. 3 mmol) and dienophile (0. 5 M CH2C12
solution 200 mL, 0. 1 mmol ) were added, followed by stirring until
the raw materialdisappears. After heating to roomtemperature,
acetic acid (ca. 75 mL) and TBAF (0.1 M THF solution, 800 mL,
0. 8 mmol ) were added, followed by stirring for 5 min. A saturated
sodium hydrogen carbonate aqueous solution was carefully added
and an aqueous phase was extracted with ethyl acetate, followed
by washing an organic phase with saturated saline solution.
Sodium sulfate was used to dry, followed by filtering and
distilling away a solvent, further followed by silica gel column
chromatography, a target subject was obtained as a mixture of
diastereomer.
OTMS Ba(O'Pr)Z (20 mol %), OH
f COOMe Ligand 2(20 mol%), CH2CI2 ,*,COOMe
Temp., Time
then
\ MeOOC TBAF, AcOH COOMe
For a alcohol: 1H NMR (CDC13, 500 MHz) d 5.88 (m, 2H) , 4.49 (m,
1H) , 3. 72 (s, 3H) , 3. 69 (s, 3H) , 2. 99 (ddd, J= 5. 5, 11. 3, 11. 8
Hz, 1H) , 2. 92 (dd, J= 4. 0, 11. 8 Hz, 1H) , 2. 48 - 2. 43 (m, 1H) ,
2. 16 - 2. 10 (m, 1H) ; For alcohol: 1H NMR (CDC13r 500 MHz) d
5.77 - 5.73 (m, 1H), 5.70 - 5.67 (m, 1H), 4.42 (m, 1H), 3.73
(s, 3H), 3.67 (s, 3H), 2.96 - 2.92 (m, 1H), 2.76 (dd, J= 8.9,
11.3 Hz, 1H), 2.41 - 2.36 (m, 1H), 2.26 - 2.20 (m, 1H); For
diastereomer mixture: 13C NMR (CDC13r 125 MHz) d 175.5, 174.1,
174 . 0, 172 . 8, 129 . 4, 128 . 9, 127 . 1, 126. 3, 68 . 5, 63 . 9, 52 . 2,
52 . 1,
52.0, 52.0, 49.8, 47.6, 40.7, 36.2, 28.7, 27.7; IR (neat, cm-1)
57
CA 02644665 2008-09-03
3460, 2953, 1736; ESI-MS m/z 237 [M + Na]+; GC (CHIRASIL-DEX
CB, column temperature 150 C, injection temperature 200 C,
detection temperature 250 C. ) : tR 12.2 min (endo / exo miture) ,
13.3 min (endo, major), 13.8 min (endo, minor).
EXAMPLES 31 to 33:
Except that, in the example 30, X of Ligand 2 was changed
to Cl (asymmetric ligand of example 29) or F and/or a reaction
time and/or a reaction temperature in the example 30 were changed,
similarly to example 30, reactions were carried out. Results
thereof are shown in Table 3 below.
(COMPARATIVE EXAMPLE 17)
Except that, in place of a ligand in the example 30, a
conventional glucose-derived ligand (ligand represented by "1"
in the tables 1 and 2) was used, a reaction was carried out in
a manner similar to example 30. Results thereof are shown in
Table 3 below.
When example 33 and comparative example 17 are compared,
it is found that the optical purity of a product of example 33
is higher. Further, when examples 30 to 33 are compared, it
is found that a ligand having a substituent group of chlorine
or fluorine in a catechol site are higher in the endo/exo ratio
and yield.
58
CA 02644665 2008-09-03
Table 3.
X Temperature Hours Yield Endo/exo Optical
Purity
Example 30 F Room Temp. llh <6% 0.8:1 88% ee
Example 31 H -200C 1.5h 34% 4.6:1 88% ee
Example 32 C1 -200C 47h 44% 11.5:1 90% ee
Example 33 F -200C 47h 48% 13.3:1 86% ee
Comparative - -200C 42h 74% 3.3:1 61% ee
Example 17
Brief description of the drawings
Fig. 1 is a scheme surveying examples 1 to 8.
59
